# EDGAR Filing Document

**Accession Number:** 0000877212
**File Stem:** 0000877212-25-000131
**Filing Date:** 2025-8
**Character Count:** 129371
**Document Hash:** 0b7e8d8a66b74a3bdd0f64421b5cc499
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000877212-25-000131.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0000877212-25-000131

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 85

**CONFORMED PERIOD OF REPORT**: 20250628

**FILED AS OF DATE**: 20250805

**DATE AS OF CHANGE**: 20250805

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ZEBRA TECHNOLOGIES CORP
- **CENTRAL INDEX KEY:** 0000877212
- **STANDARD INDUSTRIAL CLASSIFICATION:** GENERAL INDUSTRIAL MACHINERY & EQUIPMENT [3560]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 362675536
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19406
- **FILM NUMBER:** 251184957

**BUSINESS ADDRESS:**
- **STREET 1:** 3 OVERLOOK POINT
- **CITY:** LINCOLNSHIRE
- **STATE:** IL
- **ZIP:** 60069
- **BUSINESS PHONE:** 847-634-6700

**MAIL ADDRESS:**
- **STREET 1:** 3 OVERLOOK POINT
- **CITY:** LINCOLNSHIRE
- **STATE:** IL
- **ZIP:** 60069

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZEBRA TECHNOLOGIES Corp
- **DATE OF NAME CHANGE:** 20090508

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZEBRA TECHNOLOGIES CORP/DE
- **DATE OF NAME CHANGE:** 19930328

?xml version='1.0' encoding='ASCII'? zbra-20250628

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 28, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

---

| | |
|:---|:---|
|  | **For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>** |

---

**Commission File Number: 000-19406** 

**Zebra Technologies Corporation** 

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **36-2675536** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |

---

**3 Overlook Point, Lincolnshire, IL 60069** 

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: **(847) 634-6700** 

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of exchange on which registered</u>** |
| Class A Common Stock, par value $.01 per share | ZBRA | The NASDAQ Stock Market, LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 29, 2025, there were 50,845,151 shares of Class A Common Stock, $.01 par value, outstanding.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**QUARTER ENDED JUNE 28, 2025**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **PAGE** |
| **<u>[PART I - FINANCIAL INFORMATION](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_10)</u>** | **<u>[PART I - FINANCIAL INFORMATION](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_10)</u>** | [3](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_10) |
| Item 1. | [Consolidated Financial Statements](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_10) | [3](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_13) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Consolidated Balance Sheets as of June 28, 2025 (unaudited) and December 31, 2024](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_16) | [3](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_16) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Consolidated Statements of Operations (unaudited) for the three and six months ended June 28, 2025 and June 29, 2024](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_16) | [4](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_19) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Consolidated Statements of Comprehensive Income (unaudited) for the three and six months ended June 28, 2025 and June 29, 2024](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_22) | [5](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_22) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Consolidated Statements of Stockholders' Equity (unaudited) for the three and six months ended June 28, 2025 and June 29, 2024](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_25) | [6](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_25) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Consolidated Statements of Cash Flows (unaudited) for the six months ended June 28, 2025 and June 29, 2024](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_28) | [8](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_28) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Notes to Consolidated Financial Statements (unaudited)](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_31) | [8](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_31) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 1: Description of Business and Basis of Presentation](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_34) | [9](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_34) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 2: Significant Accounting Policies](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_37) | [9](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_37) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 3: Revenues](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_40) | [10](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_40) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 4: Inventories](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_43) | [11](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_43) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 5: Business Acquisitions](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_46) | [11](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_46) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 6: Investments](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_49) | [11](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_49) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 7: Fair Value Measurements](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_52) | [11](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_52) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 8: Derivative Instruments](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_55) | [13](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_55) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 9: Long-Term Debt](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_58) | [15](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_58) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 10: Leases](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_61) | [16](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_61) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 11: Accrued Liabilities, Commitments and Contingencies](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_64) | [17](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_64) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 12: Income Taxes](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_70) | [17](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_70) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 13: Earnings Per Share](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_73) | [18](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_73) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 14: Accumulated Other Comprehensive (Loss) Income](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_76) | [18](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_76) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 15: Accounts Receivable Factoring](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_79) | [19](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_79) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 16: Segment Information & Geographic Data](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_82) | [19](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_82) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Note 17: Subsequent Events](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_1104) | [20](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_1104) |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_91) | [21](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_91) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Overview](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_94) | [21](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_94) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Results of Operations](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_97) | [22](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_97) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Results of Operations by Segment](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_100) | [24](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_100) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Liquidity and Capital Resources](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_103) | [26](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_103) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Significant Customers](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_106) | [28](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_106) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Safe Harbor](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_109) | [29](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_109) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[New Accounting Pronouncements](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_112) | [29](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_112) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[Non-GAAP Measures](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_115) | [30](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_115) |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_118) | [30](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_118) |
| Item 4. | [Controls and Procedures](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_121) | [30](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_121) |
| **<u>[PART II - OTHER INFORMATION](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_124)</u>** | **<u>[PART II - OTHER INFORMATION](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_124)</u>** | [31](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_124) |
| Item 1. | [Legal Proceedings](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_127) | [31](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_127) |
| Item 1A. | [Risk Factors](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_130) | [31](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_130) |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_133) | [31](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_133) |
| Item 5. | [Other Information](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_136) | [31](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_136) |
| Item 6. | [Exhibits](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_139) | [32](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_139) |
| [Signatures](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_142) | [Signatures](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_142) | [33](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_142) |

---

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**PART I - FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Consolidated Financial Statements** |

---

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

(In millions, except share data)

---

| | | |
|:---|:---|:---|
| | **June 28,<br>2025** | **December 31,<br>2024** |
| | (Unaudited) | |
| Assets |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $872 | $901 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowances for doubtful accounts of $1 each as of June 28, 2025 and December 31, 2024 | 634 | 692 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 686 | 693 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax receivable | 50 | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 92 | 134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current assets | 2334 | 2440 |
| Property, plant and equipment, net | 314 | 305 |
| Right-of-use lease assets | 165 | 167 |
| Goodwill | 3931 | 3891 |
| Other intangibles, net | 400 | 422 |
| Deferred income taxes | 565 | 512 |
| Other long-term assets | 229 | 231 |
| Total Assets | $7938 | $7968 |
| Liabilities and Stockholders' Equity |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt | $44 | $79 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 569 | 633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 469 | 503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 457 | 453 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 55 | 36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current liabilities | 1594 | 1704 |
| Long-term debt | 2128 | 2092 |
| Long-term lease liabilities | 152 | 155 |
| Deferred income taxes | 58 | 57 |
| Long-term deferred revenue | 315 | 304 |
| Other long-term liabilities | 74 | 70 |
| Total Liabilities | 4321 | 4382 |
| Stockholders' Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $.01 par value; authorized 10,000,000 shares; none issued |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class A common stock, $.01 par value; authorized 150,000,000 shares; issued 72,151,857 shares | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 733 | 669 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost, 21,315,596 and 20,645,798 shares as of June 28, 2025 and December 31, 2024, respectively | (2147) | (1900) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 5108 | 4860 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (78) | (44) |
| Total Stockholders' Equity | 3617 | 3586 |
| Total Liabilities and Stockholders' Equity | $7938 | $7968 |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

(In millions, except share data)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **June 28,<br>2025** | **June 29,<br>2024** |
| Net sales: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tangible products | $1055 | $983 | $2117 | $1912 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Services and software | 238 | 234 | 484 | 480 |
| Total Net sales | 1293 | 1217 | 2601 | 2392 |
| Cost of sales: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tangible products | 553 | 515 | 1095 | 1013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Services and software | 124 | 113 | 245 | 227 |
| Total Cost of sales | 677 | 628 | 1340 | 1240 |
| Gross profit | 616 | 589 | 1261 | 1152 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling and marketing | 158 | 150 | 319 | 298 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 144 | 146 | 295 | 284 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 102 | 97 | 213 | 178 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 25 | 25 | 49 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition and integration costs | 4 | 1 | 7 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exit and restructuring costs |  | 3 |  | 13 |
| Total Operating expenses | 433 | 422 | 883 | 826 |
| Operating income | 183 | 167 | 378 | 326 |
| Other (loss) income, net: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange (loss) gain | (11) |  | (16) | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (25) | (23) | (48) | (40) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (9) | (8) | (11) | (11) |
| Total Other expense, net | (45) | (31) | (75) | (48) |
| Income before income tax | 138 | 136 | 303 | 278 |
| Income tax expense | 26 | 23 | 55 | 50 |
| Net income | $112 | $113 | $248 | $228 |
| Basic earnings per share | $2.20 | $2.19 | $4.85 | $4.43 |
| Diluted earnings per share | $2.19 | $2.17 | $4.81 | $4.40 |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

(In millions)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **June 28,<br>2025** | **June 29,<br>2024** |
| Net income | $112 | $113 | $248 | $228 |
| Other comprehensive income, net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in unrealized (losses) gains on sales hedging | (33) | 1 | (61) | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 20 | (3) | 27 | (8) |
| Comprehensive income | $99 | $111 | $214 | $230 |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

(In millions, except share data)

(Unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A Common Stock Shares** | **Class A Common Stock Value** | **Additional Paid-in Capital** | **Treasury Stock** | **Retained Earnings** | **Accumulated Other Comprehensive Loss** | **Total** |
| **Balance at December 31, 2024** | 51506059 | $1 | $669 | $(1900) | $4860 | $(44) | $3586 |
| Net share issuances and tax withholding payments related to share-based compensation plans | 6550 |  | (1) |  |  |  | (1) |
| Share-based compensation |  |  | 51 |  |  |  | 51 |
| Repurchase of common stock | (374358) |  |  | (125) |  |  | (125) |
| Net income |  |  |  |  | 136 |  | 136 |
| Changes in unrealized gains and losses on sales hedging (net of income taxes) |  |  |  |  |  | (28) | (28) |
| Foreign currency translation adjustment |  |  |  |  |  | 7 | 7 |
| **Balance at March 29, 2025** | 51138251 | $1 | $719 | $(2025) | $4996 | $(65) | $3626 |
| Net share issuances and tax withholding payments related to share-based compensation plans | 172677 |  | (18) | 3 |  |  | (15) |
| Share-based compensation |  |  | 32 |  |  |  | 32 |
| Repurchase of common stock | (474667) |  |  | (125) |  |  | (125) |
| Net income |  |  |  |  | 112 |  | 112 |
| Changes in unrealized gains and losses on sales hedging (net of income taxes) |  |  |  |  |  | (33) | (33) |
| Foreign currency translation adjustment |  |  |  |  |  | 20 | 20 |
| **Balance at June 28, 2025** | 50836261 | $1 | $733 | $(2147) | $5108 | $(78) | $3617 |

---

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A Common Stock Shares** | **Class A Common Stock Value** | **Additional Paid-in Capital** | **Treasury Stock** | **Retained Earnings** | **Accumulated Other Comprehensive Loss** | **Total** |
| **Balance at December 31, 2023** | 51378862 | $1 | $615 | $(1858) | $4332 | $(54) | $3036 |
| Net share issuances and tax withholding payments related to share-based compensation plans | 21106 |  | (3) |  |  |  | (3) |
| Share-based compensation |  |  | 17 |  |  |  | 17 |
| Net income |  |  |  |  | 115 |  | 115 |
| Changes in unrealized gains and losses on sales hedging (net of income taxes) |  |  |  |  |  | 9 | 9 |
| Foreign currency translation adjustment |  |  |  |  |  | (5) | (5) |
| **Balance at March 30, 2024** | 51399968 | $1 | $629 | $(1858) | $4447 | $(50) | $3169 |
| Net share issuances and tax withholding payments related to share-based compensation plans | 170023 |  | (27) | 3 |  |  | (24) |
| Share-based compensation |  |  | 31 |  |  |  | 31 |
| Net income |  |  |  |  | 113 |  | 113 |
| Changes in unrealized gains and losses on sales hedging (net of income taxes) |  |  |  |  |  | 1 | 1 |
| Foreign currency translation adjustment |  |  |  |  |  | (3) | (3) |
| **Balance at June 29, 2024** | 51569991 | $1 | $633 | $(1855) | $4560 | $(52) | $3287 |

---

Certain prior period amounts have been reclassified to conform with the current period presentation.

See accompanying Notes to Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

(In millions)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $248 | $228 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 84 | 85 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 83 | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (30) | (36) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain on forward interest rate swaps |  | (31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 12 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 81 | (185) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 11 | 125 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 10 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (71) | 98 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (101) | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 13 | (25) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes | (10) | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement liability |  | (45) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash receipts on forward interest rate swaps |  | 86 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating activities | (5) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 325 | 413 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of businesses | (62) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (37) | (24) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of short-term investments |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of long-term investments |  | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (99) | (25) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of debt issuance costs, extinguishment costs and discounts |  | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments of debt |  | (694) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of debt |  | 651 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for repurchases of common stock | (250) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net payments related to share-based compensation plans | (16) | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in unremitted cash collections from servicing factored receivables | 7 | (38) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financing activities | 2 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (257) | (115) |
| Effect of exchange rate changes on cash and cash equivalents, including restricted cash | 2 |  |
| Net (decrease) increase in cash and cash equivalents, including restricted cash | (29) | 273 |
| Cash and cash equivalents, including restricted cash, at beginning of period | 901 | 138 |
| Cash and cash equivalents, including restricted cash, at end of period | $872 | $411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less restricted cash, included in Prepaid expenses and other current assets |  |  |
| Cash and cash equivalents at end of period | $872 | $411 |
| Supplemental disclosures of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid | $95 | $43 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest paid (received) inclusive of forward interest rate swaps | $55 | $(17) |

---

See accompanying Notes to Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(Unaudited)

**Note 1 Description of Business and Basis of Presentation** 

Zebra Technologies Corporation and its subsidiaries ("Zebra" or the "Company") is a global leader providing innovative Enterprise Asset Intelligence ("EAI") products, services, and software solutions ("offerings") in the automatic identification and data capture industry. We design, manufacture, and sell a broad range of offerings, including cloud-based software subscriptions, that capture and move data. We also provide a full range of services, including maintenance, technical support, repair, managed and professional services. End-users of our offerings include those in retail and e-commerce, manufacturing, transportation and logistics, healthcare, public sector, and other industries. We provide our offerings globally through a direct sales force and an extensive network of channel partners.

Management prepared these unaudited interim consolidated financial statements according to the rules and regulations of the Securities and Exchange Commission for interim financial information and notes. As permitted under Article 10 of Regulation S-X and the instructions of Form 10-Q, these consolidated financial statements do not include all the information and notes required by United States Generally Accepted Accounting Principles ("GAAP") for complete financial statements, although management believes that the disclosures made are adequate to make the information not misleading. These interim financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

In the opinion of the Company, these interim financial statements include all adjustments (of a normal, recurring nature) necessary to fairly present its Consolidated Balance Sheet as of June 28, 2025, the Consolidated Statements of Operations, Comprehensive Income and Stockholders' Equity for the three and six months ended June 28, 2025 and June 29, 2024, and the Consolidated Statements of Cash Flows for the six months ended June 28, 2025 and June 29, 2024. These results, however, are not necessarily indicative of the results expected for the full fiscal year ending December 31, 2025.

**Note 2 Significant Accounting Policies** 

For a discussion of our significant accounting policies, see Note 2, *Significant Accounting Policies* within Part II, Item 8 "Financial Statements and Supplementary Data" in the Annual Report on Form 10-K for the year ended December 31, 2024. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended December 31, 2024.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Note 3 Revenues** 

The Company recognizes revenue to depict the transfer of goods, services, or software solutions to a customer at an amount that reflects the consideration which it expects to receive.

Revenues for tangible products are generally recognized upon shipment, whereas revenues for services are generally recognized over time by using an output or time-based method, assuming all other criteria for revenue recognition have been met. Revenues for software are recognized either upon delivery or over time using a time-based method, depending on how control is transferred to the customer. In cases where a bundle of products, services, and/or software are delivered to the customer, judgment is required to select the method of progress which best reflects the transfer of control.

*Disaggregation of Revenue*

The following table presents our Net sales disaggregated by product category for each of our segments (in millions):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** | **June 29, 2024** | **June 29, 2024** | **June 29, 2024** |
| &nbsp;&nbsp;&nbsp;**Segment** | **Tangible Products** | **Services and Software** | **Total** | **Tangible Products** | **Services and Software** | **Total** |
| &nbsp;&nbsp;&nbsp;AIT | $388 | $30 | $418 | $368 | $29 | $397 |
| &nbsp;&nbsp;&nbsp;EVM | 667 | 208 | 875 | 615 | 205 | 820 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1055 | $238 | $1293 | $983 | $234 | $1217 |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** | **June 29, 2024** | **June 29, 2024** | **June 29, 2024** |
| &nbsp;&nbsp;&nbsp;**Segment** | **Tangible Products** | **Services and Software** | **Total** | **Tangible Products** | **Services and Software** | **Total** |
| &nbsp;&nbsp;&nbsp;AIT | $820 | $60 | $880 | $733 | $56 | $789 |
| &nbsp;&nbsp;EVM | 1297 | 424 | 1721 | 1179 | 424 | 1603 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $2117 | $484 | $2601 | $1912 | $480 | $2392 |

---

In addition, refer to Note 16, *Segment Information & Geographic Data* for Net sales to customers by geographic region.

*Performance Obligations*

The Company's remaining performance obligations relate to services and software solutions. The aggregated transaction price allocated to remaining performance obligations for arrangements with an original term exceeding one year was $1.17 billion and $1.19 billion, inclusive of deferred revenue, as of June 28, 2025 and December 31, 2024, respectively. On average, remaining performance obligations as of June 28, 2025 and December 31, 2024 are expected to be recognized over a period of approximately two years.

*Contract Balances*

Progress on satisfying performance obligations under contracts with customers related to billed revenues is reflected on the Consolidated Balance Sheets in Accounts receivable, net. Progress on satisfying performance obligations under contracts with customers related to unbilled revenues ("contract assets") is reflected on the Consolidated Balance Sheets as Prepaid expenses and other current assets for revenues expected to be billed within the next twelve months, and Other long-term assets for revenues expected to be billed thereafter. The total contract asset balances were $10 million and $11 million as of June 28, 2025 and December 31, 2024, respectively. These contract assets result from timing differences between billing and satisfying performance obligations, inclusive of any impacts from the allocation of the transaction price among performance obligations for contracts that include multiple performance obligations. Contract assets are evaluated for impairment, and no impairment losses have been recognized during the three and six months ended June 28, 2025 and June 29, 2024, respectively.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

Deferred revenue on the Consolidated Balance Sheets consists of payments and billings in advance of our performance. The combined short-term and long-term deferred revenue balances were $772 million and $757 million as of June 28, 2025 and December 31, 2024, respectively. During the three and six months ended June 28, 2025, the Company recognized $117 million and $258 million in revenue, which was previously included in the beginning balance of deferred revenue as of December 31, 2024. During the three and six months ended June 29, 2024, the Company recognized $121 million and $267 million in revenue, which was previously included in the beginning balance of deferred revenue as of December 31, 2023.

**Note 4 Inventories** 

The categories of Inventories, net are as follows (in millions):

---

| | | |
|:---|:---|:---|
| | **June 28,<br>2025** | **December 31,<br>2024** |
| Raw materials <sup>(1)</sup> | $233 | $248 |
| Work in process | 2 | 4 |
| Finished goods | 451 | 441 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Inventories, net | $686 | $693 |

---

(1) Raw material inventories primarily consist of product components as well as supplies used in repair operations.

**Note 5 Business Acquisitions** 

*Photoneo*

On February 28, 2025, the Company acquired Photoneo, a leading developer and manufacturer of 3D machine vision offerings. The Company's cash purchase consideration of $62 million was primarily allocated to technology-related intangible assets of $17 million, customer relationship assets of $6 million, and goodwill of $34 million. The technology-related intangible assets and customer relationship assets both have estimated useful lives of 7 years. The Company utilized estimated fair values as of the acquisition date to allocate the purchase consideration to the identifiable net assets acquired based on estimates and assumptions, as well as customary valuation techniques. While we believe these estimates provide a reasonable basis to record the net assets acquired, the purchase price allocation is considered preliminary and subject to adjustment during the measurement period, which is up to one year from the acquisition date. The primary fair value estimates still considered preliminary as of June 28, 2025 relate to intangible assets.

The goodwill, which will be deductible for tax purposes, has been allocated to the EVM segment and principally relates to the expansion of our machine vision offerings across several industries.

**Note 6 Investments** 

The carrying value of the Company's long-term investments, which are included in Other long-term assets on the Consolidated Balance Sheets, was $100 million and $110 million as of June 28, 2025 and December 31, 2024, respectively.

The Company did not make any payments for the purchase of long-term investments during the six months ended June 28, 2025. During the six months ended June 29, 2024, the Company paid $3 million for the purchase of long-term investments. Net gains and losses related to the Company's long-term investments are included within Other expense, net on the Consolidated Statements of Operations. The Company recognized net losses of $10 million and $6 million during the three and six months ended June 28, 2025 and June 29, 2024, respectively.

**Note 7 Fair Value Measurements** 

Financial assets and liabilities are measured using inputs from three levels of the fair value hierarchy in accordance with Accounting Standards Codification ("ASC") Topic 820, *Fair Value Measurements*. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into the following three broad levels:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs (e.g. U.S. Treasuries and money market funds).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Observable prices that are based on inputs not quoted in active markets but corroborated by market data.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs. In addition, the Company considers counterparty credit risk in the assessment of fair value.

The Company's financial assets and liabilities carried at fair value as of June 28, 2025, are classified below (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments related to the deferred compensation plan | $45 | $— | $— | $45 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets at fair value | $45 | $— | $— | $45 |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts <sup>(1)</sup> | $6 | $51 | $— | $57 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities related to the deferred compensation plan | 45 |  |  | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities at fair value | $51 | $51 | $— | $102 |

---

The Company's financial assets and liabilities carried at fair value as of December 31, 2024, are classified below (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts <sup>(1)</sup> | $1 | $30 | $— | $31 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments related to the deferred compensation plan | 41 |  |  | 41 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets at fair value | $42 | $30 | $— | $72 |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities related to the deferred compensation plan | $41 | $— | $— | $41 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities at fair value | $41 | $— | $— | $41 |

---

(1)The fair value of the foreign exchange contracts is calculated as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fair value of forward contracts associated with forecasted sales hedges is calculated using the period-end exchange rate adjusted for current forward points (Level 2).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fair value of hedges against net assets denominated in foreign currencies is calculated at the period-end exchange rate adjusted for current forward points unless the hedge has been traded but not settled at period-end (Level 2). If this is the case, the fair value is calculated at the rate at which the hedge is being settled (Level 1).

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Note 8 Derivative Instruments** 

In the normal course of business, the Company is exposed to global market risks, including the effects of changes in foreign currency exchange rates and interest rates. The Company commonly uses derivative instruments to manage its exposure to such risks and may elect to designate certain derivatives as hedging instruments under ASC Topic 815, *Derivatives and Hedging* ("ASC 815"). The Company formally documents all relationships between designated hedging instruments and hedged items as well as its risk management objectives and strategies for undertaking hedge transactions. The Company does not hold or issue derivatives for trading or speculative purposes.

In accordance with ASC 815, the Company recognizes derivative instruments as either assets or liabilities on the Consolidated Balance Sheets and measures them at fair value. The following table presents the fair value of its derivative instruments (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Asset (Liability)** | **Asset (Liability)** | **Asset (Liability)** |
| | | **Fair Values as of** | **Fair Values as of** |
| |<br>**Balance Sheets Classification** | **June 28,<br>2025** | **December 31,<br>2024** |
| **Derivative instruments designated as hedges:** | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | Prepaid expenses and other current assets | $— | $30 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | Accrued liabilities | (51) |  |
| Total derivative instruments designated as hedges |  | $(51) | $30 |
| **Derivative instruments not designated as hedges:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | Prepaid expenses and other current assets | $— | $1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | Accrued liabilities | (6) |  |
| Total derivative instruments not designated as hedges |  | $(6) | $1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net derivative (liability) asset |  | $(57) | $31 |

---

The following table presents the net gains (losses) from changes in fair values of derivatives that are not designated as hedges (in millions):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Gains (Losses) Recognized in Income** | **Gains (Losses) Recognized in Income** | **Gains (Losses) Recognized in Income** | **Gains (Losses) Recognized in Income** | **Gains (Losses) Recognized in Income** |
| | | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| |<br>**Statements of Operations Classification** | **June 28,<br>2025** | **June 29,<br>2024** | **June 28,<br>2025** | **June 29,<br>2024** |
| **Derivative instruments not designated as hedges:** | | | | | |
| &nbsp;&nbsp;Foreign exchange contracts | Foreign exchange (loss) gain | $(15) | $1 | $(23) | $2 |
| &nbsp;&nbsp;Forward interest rate swaps | Interest expense, net |  | 11 |  | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net (loss) gain recognized in income |  | $(15) | $12 | $(23) | $33 |

---

Activities related to derivative instruments are reflected within Net cash provided by operating activities on the Consolidated Statements of Cash Flows.

*Interest Rate Risk Management*

The Company is exposed to market risk associated with interest rate payments on its borrowings under a term loan ("Term Loan A"), Revolving Credit Facility, and Receivables Financing Facilities, which bear interest at variable rates plus applicable margins. The Company manages its exposure to changes in interest rates by issuing both fixed and variable rate borrowings as well as periodically utilizing interest rate swaps to economically hedge interest rate exposure based on current and projected market conditions. The Company had no active interest rate swap agreements during the six months ended June 28, 2025.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

*Credit and Market Risk Management*

Financial instruments, including derivatives, expose the Company to counterparty credit risk of nonperformance and to market risk related to currency exchange rate and interest rate fluctuations. The Company manages its exposure to counterparty credit risk by establishing minimum credit standards, diversifying its counterparties, and monitoring its concentrations of credit. The Company's counterparties are commercial banks with expertise in derivative financial instruments. The Company evaluates the impact of market risk on the fair value and cash flows of its derivative and other financial instruments by considering reasonably possible changes in interest rates and currency exchange rates. The Company continually monitors the creditworthiness of the customers to which it grants credit terms in the normal course of business. The terms and conditions of the Company's credit policies are designed to mitigate concentrations of credit risk.

The Company's master netting and other similar arrangements with the respective counterparties allow for net settlement under certain conditions, which are designed to reduce credit risk by permitting net settlement with the same counterparty. We present the assets and liabilities of our derivative financial instruments, for which we have net settlement agreements in place, on a net basis on the Consolidated Balance Sheets. If the derivative financial instruments had been presented gross on the Consolidated Balance Sheets, the asset and liability positions would not have been significantly different as of June 28, 2025 or December 31, 2024.

*Foreign Currency Exchange Risk Management*

The Company conducts business on a multinational basis in a variety of foreign currencies. Exposure to market risk for changes in foreign currency exchange rates arises primarily from Euro-denominated external revenues, cross-border financing activities between subsidiaries, and foreign currency denominated monetary assets and liabilities. The Company manages its objective of preserving the economic value of non-functional currency denominated cash flows by initially hedging transaction exposures with natural offsets and, once these opportunities have been exhausted, through foreign exchange forward and option contracts, as deemed appropriate.

The Company manages the exchange rate risk of anticipated Euro-denominated sales using forward contracts, which typically mature within twelve months of execution. The Company designates these derivative contracts as cash flow hedges. Unrealized gains and losses on these contracts are deferred in Accumulated other comprehensive income (loss) ("AOCI") on the Consolidated Balance Sheets until the contract is settled and the hedged sale is realized. The realized gain or loss is then recorded as an adjustment to Net sales on the Consolidated Statements of Operations. Realized amounts reclassified to Net sales were $13 million of losses and $5 million of gains for the three months ended June 28, 2025 and June 29, 2024, respectively. Realized amounts reclassified to Net sales were $4 million of losses and $6 million of gains for the six months ended June 28, 2025 and June 29, 2024, respectively. As of June 28, 2025 and December 31, 2024, the notional amounts of the Company's foreign exchange cash flow hedges were €611 million and €592 million, respectively. The Company has reviewed its cash flow hedges for effectiveness and determined that they are highly effective.

The Company uses forward contracts, which are not designated as hedging instruments, to manage its exposures related to net assets denominated in foreign currencies. These forward contracts typically mature within one month after execution. Monetary gains and losses on these forward contracts are recorded in income and are generally offset by the transaction gains and losses related to their net asset positions. The notional values and the net fair values of these outstanding contracts were as follows (in millions):

---

| | | |
|:---|:---|:---|
| | **June 28,<br>2025** | **December 31,<br>2024** |
| Notional balance of outstanding contracts: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;British Pound/U.S. Dollar | £2 | £5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euro/U.S. Dollar | 102 | 146 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euro/Czech Koruna | 14 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Japanese Yen/U.S. Dollar | ¥662 | ¥360 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Singapore Dollar/U.S. Dollar | 13 | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mexican Peso/U.S. Dollar | 234 | 142 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Polish Zloty/U.S. Dollar | 89 | 53 |
| Net fair value of (liabilities) assets of outstanding contracts | $(6) | $1 |

---

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Note 9 Long-Term Debt** 

The following table shows the carrying value of the Company's debt (in millions):

---

| | | |
|:---|:---|:---|
| | **June 28,<br>2025** | **December 31,<br>2024** |
| Term Loan A | $1575 | $1575 |
| Senior Notes | 500 | 500 |
| Receivables Financing Facility | 108 | 108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt | $2183 | $2183 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Debt issuance costs | (9) | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Unamortized discounts | (2) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Current portion of debt | (44) | (79) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term debt | $2128 | $2092 |

---

As of June 28, 2025, the future maturities of debt are as follows (in millions):

---

| | |
|:---|:---|
| 2025 (6 months remaining) | $— |
| 2026 | 88 |
| 2027 | 1595 |
| 2028 |  |
| 2029 |  |
| Thereafter | 500 |
| Total future maturities of debt | $2183 |

---

All borrowings as of June 28, 2025 were denominated in U.S. Dollars.

The estimated fair value of the Company's debt approximated $2.2 billion as of both June 28, 2025 and December 31, 2024. These fair value amounts, developed based on inputs classified as Level 2 within the fair value hierarchy, represent the estimated value at which the Company's lenders could trade its debt within the financial markets and do not represent the settlement value of these liabilities to the Company. The fair value of debt will continue to vary each period based on a number of factors, including fluctuations in market interest rates as well as changes to the Company's credit ratings.

*Term Loan A*

The principal on Term Loan A is due in quarterly installments, with the next quarterly installment due in the first quarter of 2026 and the majority due upon maturity in 2027. The Company has made and may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. As of June 28, 2025, the Term Loan A interest rate was 5.43%. Interest payments are made monthly and are subject to variable rates plus an applicable margin.

*Senior Notes*

In the second quarter of 2024, the Company completed a private offering of $500 million senior unsecured notes (the "Senior Notes") with a 6.5% fixed interest rate. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year. The Company has the option to or could be required to prepay certain outstanding amounts in the event of certain circumstances or transactions.

The Senior Notes are fully and unconditionally guaranteed on a senior unsecured basis by certain of Zebra's existing and future subsidiaries. The Senior Notes contain covenants that, among other things, limit the ability of Zebra to: (i) grant or incur liens; (ii) have its subsidiaries guarantee debt without becoming guarantors; and (iii) merge or consolidate with another company or sell all or substantially all of its assets.

*Revolving Credit Facility*

The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of June 28, 2025, the Company had letters of credit totaling $10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $1,500 million to $1,490 million. As of June 28, 2025, there were no borrowings under the Revolving Credit Facility. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

*Receivables Financing Facility*

As of June 28, 2025, the Company has a Receivables Financing Facility with a borrowing limit of up to $180 million. As collateral, the Company pledges perfected first-priority security interests in its U.S. domestically originated accounts receivable. The Company has accounted for transactions under this facility as secured borrowings. The receivables financing facility matures on March 19, 2027.

As of June 28, 2025, the Company's Consolidated Balance Sheets included $678 million of gross receivables that were pledged under the facility. As of June 28, 2025, $108 million had been borrowed and was classified as non-current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of June 28, 2025, the facility had an average interest rate of 5.38%. Interest is paid monthly on these borrowings.

The Company's borrowings described above include terms and conditions that limit the incurrence of additional borrowings and require that certain financial ratios be maintained at designated levels.

As of June 28, 2025, the Company was in compliance with all debt covenants.

**Note 10 Leases** 

During the six months ended June 28, 2025, the Company recorded $9 million of right-of-use ("ROU") assets obtained in exchange for lease obligations primarily related to the extensions of existing leases and the commencement of new office facility leases.

Future minimum lease payments under non-cancellable leases as of June 28, 2025 were as follows (in millions):

---

| | |
|:---|:---|
| 2025 (6 months remaining) | $24 |
| 2026 | 45 |
| 2027 | 36 |
| 2028 | 33 |
| 2029 | 28 |
| Thereafter | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total future minimum lease payments** | $227 |
| Less: Interest | (39) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Present value of lease liabilities** | $188 |
| **Reported as of June 28, 2025:** |  |
| Current portion of lease liabilities | $36 |
| Long-term lease liabilities | 152 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Present value of lease liabilities** | $188 |

---

The current portion of lease liabilities is included within Accrued liabilities on the Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Note 11 Accrued Liabilities, Commitments and Contingencies** 

*Accrued Liabilities*

The components of Accrued liabilities are as follows (in millions):

---

| | | |
|:---|:---|:---|
| | **June 28,<br>2025** | **December 31,<br>2024** |
| Incentive compensation | $78 | $174 |
| Payroll and benefits | 76 | 76 |
| Unremitted cash collections due to banks on factored accounts receivable | 58 | 51 |
| Foreign exchange contracts | 57 |  |
| Customer rebates | 54 | 56 |
| Current portion of lease liabilities | 36 | 36 |
| Warranty | 27 | 26 |
| Freight and duty | 11 | 12 |
| Other | 72 | 72 |
| Accrued liabilities | $469 | $503 |

---

*Warranties*

The following table is a summary of the Company's warranty obligations (in millions):

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** |
| Balance at the beginning of the period | $26 | $27 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warranty expense | 18 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warranties fulfilled | (17) | (13) |
| Balance at the end of the period | $27 | $27 |

---

*Contingencies*

The Company is subject to a variety of investigations, claims, suits, and other legal proceedings that arise from time to time in the ordinary course of business, including but not limited to, intellectual property, employment, tort, and breach of contract matters. The Company currently believes that the outcomes of such proceedings, individually and in the aggregate, will not have a material adverse impact on its business, cash flows, financial position, or results of operations. Any legal proceedings are subject to inherent uncertainties, and the Company's view of these matters and their potential effects may change in the future. The Company records a liability for contingencies when a loss is deemed to be probable and the loss can be reasonably estimated.

**Note 12 Income Taxes**

The Company's effective tax rate for the three and six months ended June 28, 2025 was 18.8% and 18.2%, respectively, compared to 16.9% and 18.0% for the three and six months ended June 29, 2024. In the current and prior periods, the variance from the 21% federal statutory rate was primarily attributable to the generation of U.S. tax credits and the tax benefit related to foreign earnings subject to U.S. taxation, offset partially by U.S. state income taxes.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Note 13 Earnings Per Share** 

Basic net earnings per share is calculated by dividing net income by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average number of diluted common shares outstanding. Diluted common shares outstanding is computed using the Treasury Stock method and, in periods of income, reflects the additional shares that would be outstanding if dilutive share-based compensation awards were converted into common shares during the period.

Earnings per share (in millions, except share data):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **June 28,<br>2025** | **June 29,<br>2024** |
| Basic: |  |  |  |  |
| Net income | $112 | $113 | $248 | $228 |
| Weighted-average shares outstanding | 50939474 | 51489735 | 51154241 | 51444179 |
| Basic earnings per share | $2.20 | $2.19 | $4.85 | $4.43 |
| Diluted: |  |  |  |  |
| Net income | $112 | $113 | $248 | $228 |
| Weighted-average shares outstanding | 50939474 | 51489735 | 51154241 | 51444179 |
| Dilutive shares | 342799 | 340510 | 392169 | 371720 |
| Diluted weighted-average shares outstanding | 51282273 | 51830245 | 51546410 | 51815899 |
| Diluted earnings per share | $2.19 | $2.17 | $4.81 | $4.40 |

---

Anti-dilutive share-based compensation awards are excluded from diluted earnings per share calculations. There were 199,500 and 126,172 shares that were anti-dilutive for the three and six months ended June 28, 2025, respectively. There were 164,004 and 91,050 shares that were anti-dilutive for the three and six months ended June 29, 2024, respectively.

**Note 14 Accumulated Other Comprehensive (Loss) Income** 

Stockholders' equity includes certain items classified as AOCI, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Unrealized gain (loss) on sales hedging** which relates to derivative instruments used to hedge the exposure related to currency exchange rates for forecasted Euro sales. These hedges are designated as cash flow hedges, and the Company defers income statement recognition of gains and losses until the hedged transaction occurs. See Note 8, *Derivative Instruments* for more details.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Foreign currency translation adjustments** which relates to the Company's non-U.S. subsidiary companies that have designated a functional currency other than the U.S. Dollar. The Company translates the subsidiary functional currency financial statements to U.S. Dollars using a combination of historical, period-end, and average foreign exchange rates. This combination of rates creates the foreign currency translation adjustment component of AOCI.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

The changes in each component of AOCI during the six months ended June 28, 2025 and June 29, 2024 were as follows (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Unrealized gain (loss) on sales hedging** | **Foreign currency translation adjustments** | **Total** |
| Balance at December 31, 2023 | $(5) | $(49) | $(54) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 20 | (8) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI<sup>(1)</sup> | (6) |  | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax effect | (4) |  | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | 10 | (8) | 2 |
| Balance at June 29, 2024 | $5 | $(57) | $(52) |
| Balance at December 31, 2024 | $22 | $(66) | $(44) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | (85) | 27 | (58) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCI<sup>(1)</sup> | 4 |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax effect | 20 |  | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | (61) | 27 | (34) |
| Balance at June 28, 2025 | $(39) | $(39) | $(78) |

---

(1) See Note 8, *Derivative Instruments* regarding the timing of reclassifications to operating results.

**Note 15 Accounts Receivable Factoring** 

The Company has a Receivables Factoring arrangement, pursuant to which certain receivables originated from the EMEA and Asia-Pacific regions up to a maximum of €75 million are sold to a bank without recourse in exchange for cash. Such transfers are accounted for as sales and the related receivables are removed from the Company's balance sheet. The Company does not maintain any beneficial interest in the receivables sold. The Company services the receivables on behalf of the bank, but otherwise maintains no significant continuing involvement with respect to the receivables. Sale proceeds that are representative of the fair value of factored receivables, less a factoring fee, are reflected in Cash flows from operating activities on the Consolidated Statements of Cash Flows, while sale proceeds in excess of the fair value of factored receivables are reflected in Cash flows from financing activities on the Consolidated Statements of Cash Flows.

During the six months ended June 28, 2025 and June 29, 2024, the Company received cash proceeds of $246 million and $607 million, respectively, from the sales of accounts receivables under its factoring arrangement. As of June 28, 2025 and December 31, 2024, there were a total of $30 million and $28 million, respectively, of uncollected receivables that had been sold and removed from the Company's Consolidated Balance Sheets.

As servicer of sold receivables, the Company had $58 million and $51 million of obligations that were not yet remitted to the bank as of June 28, 2025 and December 31, 2024, respectively. These obligations are included within Accrued liabilities on the Consolidated Balance Sheets, with changes in such obligations reflected within Cash flows from financing activities on the Consolidated Statements of Cash Flows.

**Note 16 Segment Information & Geographic Data**

The Company's operations consist of two reportable segments that provide complementary offerings to our customers: Asset Intelligence & Tracking ("AIT"), which includes barcode and card printing, RFID and RTLS offerings, supplies, and services; and Enterprise Visibility & Mobility ("EVM"), which includes mobile computing, data capture, fixed industrial scanning and machine vision, services, and workflow optimization solutions. The reportable segments have been identified based on the financial data utilized by the Company's Chief Executive Officer (the chief operating decision maker or "CODM") to assess segment performance and allocate resources among the Company's segments. The CODM reviews adjusted operating income to assess segment profitability primarily during the Company's annual budget and forecasting process. The CODM assesses the profitability of each segment relative to its long-term growth objectives in evaluating resource allocation priorities. Segment assets are not reviewed by the Company's CODM and therefore are not disclosed below.

Financial information by segment is presented as follows (in millions):

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **June 28,<br>2025** | **June 29,<br>2024** |
| &nbsp;&nbsp;&nbsp;**Net sales:** | | | | |
| &nbsp;&nbsp;AIT | $418 | $397 | $880 | $789 |
| &nbsp;&nbsp;EVM | 875 | 820 | 1721 | 1603 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Net sales | $1293 | $1217 | $2601 | $2392 |
| **Cost of sales:** |  |  |  |  |
| &nbsp;&nbsp;AIT | $215 | $210 | $441 | $418 |
| &nbsp;&nbsp;EVM | 462 | 418 | 899 | 822 |
| **Operating expenses:** |  |  |  |  |
| &nbsp;&nbsp;AIT <sup>(1)</sup> | $120 | $114 | $256 | $222 |
| &nbsp;&nbsp;EVM <sup>(1)</sup> | 284 | 279 | 571 | 538 |
| &nbsp;&nbsp;&nbsp;**Operating income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AIT <sup>(2)</sup> | $83 | $73 | $183 | $149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EVM <sup>(2)</sup> | 129 | 123 | 251 | 243 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total segment operating income | 212 | 196 | 434 | 392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate <sup>(3)</sup> | (29) | (29) | (56) | (66) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Operating income | $183 | $167 | $378 | $326 |

---

(1)AIT and EVM segment operating expenses include Selling and marketing, Research and development, and General and administrative expenses, excluding the amounts classified within Corporate.

(2)AIT and EVM segment operating income includes depreciation and share-based compensation expense. The depreciation and share-based compensation expense amounts are proportionate to each segment's Net sales.

(3)To the extent applicable, amounts included in Corporate consist of Amortization of intangible assets, Acquisition and integration costs, Exit and restructuring costs, as well as certain other non-recurring costs (impairment of goodwill and other intangibles, and business acquisition purchase accounting adjustments).

Information regarding the Company's operations by geographic area is contained in the following tables. Net sales amounts are attributed to geographic area based on customer location.

Net sales by region were as follows (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **June 28,<br>2025** | **June 29,<br>2024** |
| North America | $647 | $599 | $1303 | $1211 |
| EMEA | 415 | 419 | 858 | 799 |
| Asia-Pacific | 141 | 118 | 266 | 230 |
| Latin America | 90 | 81 | 174 | 152 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Net sales | $1293 | $1217 | $2601 | $2392 |

---

**Note 17 Subsequent Events**

*<u>Agreement to acquire Elo</u>*

On August 3, 2025, the Company entered into a definitive agreement to acquire Elo Holdings, Inc., the sole stockholder of Elo Touch Solutions, Inc., an innovator of solutions that engage customers, enhance self-service, and accelerate automation across a wide range of end markets. The purchase price of approximately $1.3 billion (subject to customary adjustments for working capital, cash and debt) is expected to be funded with a combination of cash on hand and financing from our credit facility. The transaction is subject to standard closing conditions, including required regulatory approvals, and is expected to close in 2025. The acquired business will become part of the EVM segment.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

*<u>The One Big Beautiful Bill</u>*

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill ("OBBB"). The OBBB makes permanent key elements of the U.S. Tax Cuts and Jobs Act, including 100% bonus depreciation and the business interest expense limitation while also revising the expensing conventions related to domestic research and development costs. ASC 740, *Income Taxes*, requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the effects of the OBBB, with any impacts expected to be recognized beginning in the third quarter of 2025.

---

| | |
|:---|:---|
| **Item 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

**Overview**

We are a global leader in the Automatic Identification and Data Capture ("AIDC") industry. The AIDC market consists of mobile computing, data capture, radio frequency identification devices ("RFID"), barcode printing, and other workflow automation offerings. The Company's offerings are proven to help our customers and end-users digitize and automate their workflows to achieve their critical business objectives, including improved productivity and operational efficiency, optimized regulatory compliance, and better customer experiences.

We design, manufacture, and sell a broad range of AIDC offerings, including: mobile computers, barcode scanners and imagers, RFID readers, specialty printers for barcode labeling and personal identification, real-time location systems ("RTLS"), related accessories and supplies, such as labels and other consumables, and related software applications. We also provide machine vision and robotics automation solutions; a full range of services, including maintenance, technical support, repair, managed and professional services; as well as cloud-based software subscriptions. End-users of our offerings include those in retail and e-commerce, manufacturing, transportation and logistics, healthcare, public sector, and other industries within North America; Europe, Middle East, and Africa ("EMEA"); Asia Pacific; and Latin America.

We continue to advance our Enterprise Asset Intelligence ("EAI") vision: every asset and front-line worker visible, connected, and fully optimized. Through continual innovation, we have expanded beyond the traditional AIDC market to transform activities such as factory production, packages moving through a supply chain, retail shopping, the hospital patient journey and first responders addressing public safety and emergency situations. Data from enterprise assets, including status, condition, location, utilization, and preferences, is analyzed in the cloud to provide prioritized actionable insights. As a result, our offerings enable enterprises to "sense, analyze, and act" more effectively to optimize their activities.

The Company's operations consist of two reportable segments that provide complementary offerings to our customers: Asset Intelligence & Tracking ("AIT") and Enterprise Visibility & Mobility ("EVM").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* The AIT segment is an industry leader in barcode printing and asset tracking technologies. Its major product lines include barcode and card printers, RFID and RTLS offerings, and supplies, including temperature-monitoring labels, and services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* The EVM segment is an industry leader in automatic information and data capture offerings. Its major product lines include mobile computing, data capture, fixed industrial scanning and machine vision, services, and workflow optimization solutions. Our workflow optimization solutions include cloud-based software subscriptions, retail solutions, and robotic automation solutions.

We are a market leader in our core businesses, which are generally considered to be comprised of our mobile computing and data capture offerings, printing and supplies offerings, as well as support and repair services. We continue to focus on growth opportunities within adjacent and expansion markets by scaling and integrating our recent business acquisitions.

**Second Quarter 2025 Financial Summary and Other Recent Developments**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net sales were $1,293 million in the current quarter compared to $1,217 million in the prior year second quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Operating income was $183 million in the current quarter compared to $167 million in the prior year second quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income was $112 million, or $2.19 per diluted share in the current quarter, compared to net income of $113 million, or $2.17 per diluted share in the prior year second quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We repurchased $250 million of common shares year to date, including $125 million in the second quarter.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

Largely consistent with the first quarter of this year, both of our segments benefited from improved demand trends that began in the second half of last year. Developments in the trade policies of the U.S. and other countries, including China, negatively impacted our second quarter operating results. The impacts, including the amount and timing of proposed tariffs, remain complex and rapidly evolving and are expected to negatively impact our operating results in the second half of 2025 as well, based on facts as we understand them today. We have partially mitigated, and expect to continue to further mitigate, the impacts of these trade policies through a combination of diversifying our product sourcing footprint, targeted list price increases, and product portfolio optimization.

**Results of Operations**

***Consolidated Results of Operations***

(amounts in millions, except percentages)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** |
| Net sales: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tangible products | $1055 | $983 | $72 | 7.3% | $2117 | $1912 | $205 | 10.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Services and software | 238 | 234 | 4 | 1.7% | 484 | 480 | 4 | 0.8% |
| Total Net sales | 1293 | 1217 | 76 | 6.2% | 2601 | 2392 | 209 | 8.7% |
| Gross profit | 616 | 589 | 27 | 4.6% | 1261 | 1152 | 109 | 9.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross margin* | *47.6 %* | *48.4 %* |  | *(80) bps* | *48.5 %* | *48.2 %* |  | *30 bps* |
| Operating expenses | 433 | 422 | 11 | 2.6% | 883 | 826 | 57 | 6.9% |
| Operating income | $183 | $167 | $16 | 9.6% | $378 | $326 | $52 | 16.0% |

---

Net sales to customers by geographic region were as follows (amounts in millions, except percentages):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** |
| North America | $647 | $599 | $48 | 8.0% | $1303 | $1211 | $92 | 7.6% |
| EMEA | 415 | 419 | (4) | (1.0)% | 858 | 799 | 59 | 7.4% |
| Asia-Pacific | 141 | 118 | 23 | 19.5% | 266 | 230 | 36 | 15.7% |
| Latin America | 90 | 81 | 9 | 11.1% | 174 | 152 | 22 | 14.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Net sales | $1293 | $1217 | $76 | 6.2% | $2601 | $2392 | $209 | 8.7% |

---

Operating expenses are summarized below (amounts in millions, except percentages):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **As a % of Net sales** | **As a % of Net sales** | **June 28,<br>2025** | **June 29,<br>2024** | **As a % of Net sales** | **As a % of Net sales** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **2025** | **2024** | **June 28,<br>2025** | **June 29,<br>2024** | **2025** | **2024** |
| Selling and marketing | $158 | $150 | 12.2% | 12.3% | $319 | $298 | 12.3% | 12.5% |
| Research and development | 144 | 146 | 11.1% | 12.0% | 295 | 284 | 11.3% | 11.9% |
| General and administrative | 102 | 97 | 7.9% | 8.0% | 213 | 178 | 8.2% | 7.4% |
| Amortization of intangible assets | 25 | 25 | NM | NM | 49 | 51 | NM | NM |
| Acquisition and integration costs | 4 | 1 | NM | NM | 7 | 2 | NM | NM |
| Exit and restructuring costs |  | 3 | NM | NM |  | 13 | NM | NM |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Operating expenses | $433 | $422 | 33.5% | 34.7% | $883 | $826 | 33.9% | 34.5% |

---

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

Consolidated Organic Net sales growth:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**June 28, 2025** | **Six Months Ended**<br>**June 28, 2025** |
| Reported GAAP Consolidated Net sales growth | 6.2% | 8.7% |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of foreign currency translations <sup>(1)</sup> | 0.3% | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of acquisitions <sup>(2)</sup> | (0.2)% | (0.1)% |
| Consolidated Organic Net sales growth <sup>(3)</sup> | 6.3% | 9.0% |

---

(1)Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by translating the current period results at the currency exchange rates used in the comparable prior year period as well as removing realized cash flow hedge gains and losses from both the current and prior year periods.

(2)For purposes of computing Organic Net sales growth, amounts directly attributable to business acquisitions are excluded for twelve months following their respective acquisitions.

(3)Consolidated Organic Net sales growth is a non-GAAP financial measure. See the *Non-GAAP Measures* section at the end of this item.

*<u>Second quarter 2025 compared to Second quarter 2024</u>* 

Total Net sales increased by $76 million or 6.2% compared to the prior year quarter, reflecting growth in both of our segments. Our overall sales growth reflects improved demand trends that began in the middle of 2024 and continued in the North America, Asia-Pacific, and Latin America regions in the second quarter. Excluding the effects of currency changes and acquisitions, Consolidated Organic Net sales increased by 6.3%.

Gross margin decreased to 47.6% for the current quarter compared to 48.4% for the prior year, primarily due to unfavorable impacts of tariffs, net of mitigating actions*.* As compared to the prior year quarter, Gross margin was higher in our AIT segment and lower in our EVM segment.

Operating expenses for the quarters ended June 28, 2025 and June 29, 2024 were $433 million and $422 million, or 33.5% and 34.7% of Net sales, respectively. Current year Operating expenses were higher than the prior year quarter primarily due to increased employee and employee-related costs, as well as the unfavorable effects of foreign currency exchange rates.

Operating income was $183 million for the current quarter compared to $167 million in the prior year quarter. The increase was due to higher Gross profit, partially offset by higher Operating expenses.

Net income was slightly lower compared to the prior year quarter primarily due to higher Other expense, net partially offset by higher Operating income, as described above. The increase in Other expense, net was primarily due to foreign exchange losses in the current quarter.

The Company's effective tax rates for the three months ended June 28, 2025 and June 29, 2024 were 18.8% and 16.9%, respectively. The increase in the effective tax rate year over year was primarily due to reduced benefits from share-based compensation deductions.

Diluted earnings per share increased to $2.19 as compared to $2.17 in the prior year quarter driven by the Company's share repurchase program which reduced the number of shares outstanding.

*<u>Year to date 2025 compared to Year to date 2024</u>* 

Total Net sales increased by $209 million or 8.7% compared to the prior year period, reflecting growth in both of our segments associated with improved demand trends that began in the middle of 2024. Excluding the effects of currency changes and acquisitions, Consolidated Organic Net sales increased by 9.0%.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

Gross margin increased to 48.5% for the current year compared to 48.2% for the prior year period, primarily due to favorable business mix and volume leverage, largely offset by unfavorable impacts of tariffs, net. As compared to the prior year period, Gross margin was higher in our AIT segment and lower in our EVM segment.

Operating expenses for the six months ended June 28, 2025 and June 29, 2024 were $883 million and $826 million, or 33.9% and 34.5% of Net sales, respectively. Current year Operating expenses were higher than the prior year period primarily due to increased employee and employee-related costs, including higher incentive compensation resulting from changes in share-based compensation eligibility provisions. These increases were partially offset by lower Exit and restructuring costs.

Operating income was $378 million for the current year compared to $326 million in the prior year period. The increase was due to higher Gross profit, partially offset by higher Operating expenses.

Net income increased compared to the prior year period primarily due to higher Operating income, as described above, partly offset by higher Other expense, net. The increase in Other expense, net was primarily due to non-recurring interest rate swap gains in the prior year.

The Company's effective tax rates for the six months ended June 28, 2025 and June 29, 2024 were 18.2% and 18.0%, respectively. The increase in the effective tax rate was primarily due to higher U.S. tax credits and tax benefits related to foreign earnings subject to U.S. taxation, partly offset by reduced benefits from share-based compensation deductions.

Diluted earnings per share increased to $4.81 as compared to $4.40 in the prior year period primarily due to higher Net income.

***Results of Operations by Segment***

The following commentary should be read in conjunction with the financial results of each reportable business segment as detailed in Note 16, *Segment Information & Geographic Data* in the Notes to Consolidated Financial Statements. To the extent applicable, segment operating income excludes business acquisition purchase accounting adjustments, amortization of intangible assets, acquisition and integration costs, impairment of goodwill and other intangibles, exit and restructuring costs, as well as certain other non-recurring costs.

***Asset Intelligence & Tracking Segment ("AIT")***

(amounts in millions, except percentages)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** |
| Net sales: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tangible products | $388 | $368 | $20 | 5.4% | $820 | $733 | $87 | 11.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Services and software | 30 | 29 | 1 | 3.4% | 60 | 56 | 4 | 7.1% |
| Total Net sales | 418 | 397 | 21 | 5.3% | 880 | 789 | 91 | 11.5% |
| Gross profit | 203 | 187 | 16 | 8.6% | 439 | 371 | 68 | 18.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross margin* | *48.6 %* | *47.1 %* |  | *150 bps* | *49.9 %* | *47.0 %* |  | *290 bps* |
| Operating expenses | 120 | 114 | 6 | 5.3% | 256 | 222 | 34 | 15.3% |
| Operating income | $83 | $73 | $10 | 13.7% | $183 | $149 | $34 | 22.8% |

---

AIT Organic Net sales growth:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**June 28, 2025** | **Six Months Ended**<br>**June 28, 2025** |
| AIT Reported GAAP Net sales growth | 5.3% | 11.5% |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of foreign currency translations <sup>(1)</sup> | 0.5% | 0.5% |
| AIT Organic Net sales growth <sup>(2)</sup> | 5.8% | 12.0% |

---

(1)Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

translating the current period results at the currency exchange rates used in the comparable prior year period as well as removing realized cash flow hedge gains and losses from both the current and prior year periods.

(2)AIT Organic Net sales growth is a non-GAAP financial measure. See the *Non-GAAP Measures* section at the end of this item.

*<u>Second quarter 2025 compared to Second quarter 2024</u>*

Total Net sales for AIT increased $21 million or 5.3% compared to the prior year, primarily due to higher sales of printing and RFID products. Excluding the impact of foreign currency changes, AIT Organic Net sales increased by 5.8%.

Gross margin increased to 48.6% in the current year compared to 47.1% for the prior year, primarily due to favorable business mix and volume leverage along with lower inventory related charges, partly offset by unfavorable impacts of tariffs, net.

Operating income increased 13.7% in the current year compared to the prior year due to higher Gross profit, partly offset by higher Operating expenses.

*<u>Year to date 2025 compared to Year to date 2024</u>* 

Total Net sales for AIT increased $91 million or 11.5% compared to the prior year, primarily due to higher sales of printing and RFID products. Excluding the impact of foreign currency changes, AIT Organic Net sales increased by 12.0%.

Gross margin increased to 49.9% in the current year compared to 47.0% for the prior year, primarily due favorable business mix and volume leverage along with lower inventory related charges, partly offset by unfavorable impacts of tariffs, net.

Operating income increased 22.8% in the current year compared to the prior year due to higher Gross profit, partly offset by higher Operating expenses.

***Enterprise Visibility & Mobility Segment ("EVM")***

(amounts in millions, except percentages)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** | **% Change** |
| Net sales: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tangible products | $667 | $615 | $52 | 8.5% | $1297 | $1179 | $118 | 10.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Services and software | 208 | 205 | 3 | 1.5% | 424 | 424 |  | —% |
| Total Net sales | 875 | 820 | 55 | 6.7% | 1721 | 1603 | 118 | 7.4% |
| Gross profit | 413 | 402 | 11 | 2.7% | 822 | 781 | 41 | 5.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross margin* | *47.2 %* | *49.0 %* |  | *(180) bps* | *47.8 %* | *48.7 %* |  | *(90) bps* |
| Operating expenses | 284 | 279 | 5 | 1.8% | 571 | 538 | 33 | 6.1% |
| Operating income | $129 | $123 | $6 | 4.9% | $251 | $243 | $8 | 3.3% |

---

EVM Organic Net sales growth:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**June 28, 2025** | **Six Months Ended**<br>**June 28, 2025** |
| EVM Reported GAAP Net sales growth | 6.7% | 7.4% |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of foreign currency translations <sup>(1)</sup> | 0.1% | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impact of acquisitions <sup>(2)</sup> | (0.3)% | (0.2)% |
| EVM Organic Net sales growth <sup>(3)</sup> | 6.5% | 7.5% |

---

(1)Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

translating the current period results at the currency exchange rates used in the comparable prior year period as well as removing realized cash flow hedge gains and losses from both the current and prior year periods.

(2)For purposes of computing EVM Organic Net sales growth, amounts directly attributable to business acquisitions are excluded for twelve months following their respective acquisitions.

(3)EVM Organic Net sales growth is a non-GAAP financial measure. See the *Non-GAAP Measures* section at the end of this item.

*<u>Second quarter 2025 compared to Second quarter 2024</u>*

Total Net sales for EVM increased $55 million or 6.7% compared to the prior year, primarily due to higher sales of mobile computing products. Excluding the impacts of foreign currency changes and acquisitions, EVM Organic Net sales increased by 6.5%.

Gross margin decreased to 47.2% in the current year compared to 49.0% for the prior year, primarily due to unfavorable impacts of tariffs, net, and lower services and software margins.

Operating income for the current year increased by 4.9% compared to the prior year due to higher Gross profit, partly offset by higher Operating expenses.

*<u>Year to date 2025 compared to Year to date 2024</u>* 

Total Net sales for EVM increased $118 million or 7.4% compared to the prior year, primarily due to higher sales of mobile computing and data capture products. Excluding the impacts of foreign currency changes and acquisitions, EVM Organic Net sales increased by 7.5%.

Gross margin decreased to 47.8% in the current year compared to 48.7% for the prior year, primarily due to unfavorable impacts of tariffs, net, and lower services and software margins, partly offset by volume leverage.

Operating income for the current year increased by 3.3% compared to the prior year due to higher Gross profit, largely offset by higher Operating expenses.

**Liquidity and Capital Resources**

The primary factors that influence our liquidity include the amount and timing of cash collections from our customers, cash payments to our suppliers, capital expenditures, acquisitions, and share repurchases. Management believes that our existing capital resources, inclusive of available borrowing capacity on debt and other financing facilities and funds generated from operations, are sufficient to meet anticipated capital requirements and service our indebtedness. The following table summarizes our cash flow activities for the periods indicated (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| **Cash flow provided by (used in):** | **June 28,<br>2025** | **June 29,<br>2024** | **$ Change** |
| Operating activities | $325 | $413 | $(88) |
| Investing activities | (99) | (25) | (74) |
| Financing activities | (257) | (115) | (142) |
| Effect of exchange rates on cash balances | 2 |  | 2 |
| &nbsp;&nbsp;Net change in cash and cash equivalents, including restricted cash | $(29) | $273 | $(302) |

---

The change in our cash and cash equivalents balance during the six months ended June 28, 2025 compared to the prior year was primarily due to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $88 million decrease in net operating cash inflows primarily due to higher employee incentive compensation and income tax payments in the current year and cash receipts from the settlements of terminated interest rate swap agreements and larger reductions in inventory in the prior year. These items were partly offset by favorable timing of customer collections.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $74 million increase in net investing cash outflows primarily due to cash payments for the acquisition of Photoneo and higher capital expenditures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $142 million increase in net financing cash outflows primarily due to share repurchases in the current year, partially offset by net debt repayments in the prior year.

*Company Debt*

The following table shows the carrying value of the Company's debt (in millions):

---

| | | |
|:---|:---|:---|
| | **June 28,<br>2025** | **December 31,<br>2024** |
| Term Loan A | $1575 | $1575 |
| Senior Notes | 500 | 500 |
| Receivables Financing Facility | 108 | 108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt | $2183 | $2183 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Debt issuance costs | (9) | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Unamortized discounts | (2) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Current portion of debt | (44) | (79) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term debt | $2128 | $2092 |

---

*Term Loan A*

The principal on Term Loan A is due in quarterly installments, with the next quarterly installment due in the first quarter of 2026 and the majority due upon maturity in 2027. The Company has made and may make prepayments in whole or in part, without premium or penalty, and would be required to prepay certain outstanding amounts in the event of certain circumstances or transactions. As of June 28, 2025, the Term Loan A interest rate was 5.43%. Interest payments are made monthly and are subject to variable rates plus an applicable margin.

*Senior Notes*

In the second quarter of 2024, the Company completed a private offering of $500 million senior unsecured notes (the "Senior Notes") with a 6.5% fixed interest rate. The Senior Notes mature on June 1, 2032, and interest is payable semi-annually in arrears in June and December of each year. The Company has the option to or could be required to prepay certain outstanding amounts in the event of certain circumstances or transactions.

The Senior Notes are fully and unconditionally guaranteed on a senior unsecured basis by certain of Zebra's existing and future subsidiaries. The Senior Notes contain covenants that, among other things, limit the ability of Zebra to: (i) grant or incur liens; (ii) have its subsidiaries guarantee debt without becoming guarantors; and (iii) merge or consolidate with another company or sell all or substantially all of its assets.

*Revolving Credit Facility*

The Company has a Revolving Credit Facility that is available for working capital and other general business purposes, including letters of credit. As of June 28, 2025, the Company had letters of credit totaling $10 million, which reduced funds available for borrowings under the Revolving Credit Facility from $1,500 million to $1,490 million. As of June 28, 2025, there were no borrowings under the Revolving Credit Facility. Upon borrowing, interest payments are made monthly and are subject to variable rates plus an applicable margin. The Revolving Credit Facility matures on May 25, 2027.

*Receivables Financing Facility*

As of June 28, 2025, the Company has a Receivables Financing Facility with a borrowing limit of up to $180 million. As collateral, the Company pledges perfected first-priority security interests in its U.S. domestically originated accounts receivable. The Company has accounted for transactions under this facility as secured borrowings. The receivables financing facility matures on March 19, 2027.

As of June 28, 2025, the Company's Consolidated Balance Sheets included $678 million of gross receivables that were pledged under the facility. As of June 28, 2025, $108 million had been borrowed and was classified as non-current. Borrowings under the facility bear interest at a variable rate plus an applicable margin. As of June 28, 2025, the facility had an average interest rate of 5.38%. Interest is paid monthly on these borrowings.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

The Company's borrowings described above include terms and conditions that limit the incurrence of additional borrowings and require that certain financial ratios be maintained at designated levels.

*Receivables Factoring*

The Company has a Receivables Factoring arrangement, pursuant to which certain receivables originated from the EMEA and Asia-Pacific regions up to a maximum of €75 million are sold to a bank without recourse in exchange for cash. Such transfers are accounted for as sales and the related receivables are removed from the Company's balance sheet. The Company does not maintain any beneficial interest in the receivables sold. The Company services the receivables on behalf of the bank, but otherwise maintains no significant continuing involvement with respect to the receivables. Sale proceeds that are representative of the fair value of factored receivables, less a factoring fee, are reflected in Cash flows from operating activities on the Consolidated Statements of Cash Flows, while sale proceeds in excess of the fair value of factored receivables are reflected in Cash flows from financing activities on the Consolidated Statements of Cash Flows.

As of June 28, 2025 and December 31, 2024, there were a total of $30 million and $28 million, respectively, of uncollected receivables that had been sold and removed from the Company's Consolidated Balance Sheets.

As servicer of sold receivables, the Company had $58 million and $51 million of obligations that were not yet remitted to the bank as of June 28, 2025 and December 31, 2024, respectively. These obligations are included within Accrued liabilities on the Consolidated Balance Sheets, with changes in such obligations reflected within Cash flows from financing activities on the Consolidated Statements of Cash Flows.

See Note 15, *Accounts Receivable Factoring* in the Notes to Consolidated Financial Statements for further details.

*Share Repurchases*

On May 17, 2022, the Company announced that its Board of Directors authorized a share repurchase program for up to $1 billion of its outstanding shares of common stock. The authorized share repurchase program does not have a stated expiration date. The level of the Company's repurchases depends on a number of factors, including its financial condition, capital requirements, cash flows, results of operations, future business prospects and other factors its management may deem relevant. The timing, volume, and nature of repurchases are subject to market conditions, applicable securities laws and other factors and may be amended, suspended or discontinued at any time. Repurchases may be effected from time to time through open market purchases, including pursuant to a pre-set trading plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934.

During the first six months of 2025, the Company repurchased 849,025 shares of common stock for approximately $250 million. As of June 28, 2025, the Company has cumulatively repurchased 1,388,599 shares of common stock for approximately $404 million, resulting in a remaining amount of share repurchases authorized under the May 2022 program of $596 million.

**Significant Customers**

End-users of our offerings are diversified across a wide variety of industries. We have three customers, who are distributors of the Company's offerings, that individually accounted for more than 10% of our Net sales for the periods presented. In the aggregate, the approximate percentage of our segment and Company total Net sales attributable to these customers was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28, 2025** | **June 28, 2025** | **June 28, 2025** | **June 29, 2024** | **June 29, 2024** | **June 29, 2024** |
| | **AIT** | **EVM** | **Total** | **AIT** | **EVM** | **Total** |
| Significant customers as a % of Net sales | 19% | 41% | 60% | 18% | 37% | 55% |

---

These customers accounted for 58% of accounts receivable as of June 28, 2025. No other customer accounted for more than 10% of total Net sales during the period ended June 28, 2025.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Safe Harbor**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Market acceptance of the Company's products, services, and software solutions and competitors' offerings and the potential effects of emerging technologies and changes in customer requirements,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of global market conditions, including the North America; EMEA; Latin America; and Asia-Pacific regions in which we do business,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of changes in foreign exchange rates, customs duties and trade policies due to the global nature of Zebra's business,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to control manufacturing and operating costs,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Risks related to the manufacturing of the Company's products and conducting business operations in non-U.S. countries, including the risk of depending on key suppliers who are also in non-U.S. countries,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's ability to purchase sufficient materials, parts, and components, our ability to provide services, software, and products to meet customer demand, particularly in light of global economic conditions,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The availability of credit and the volatility of capital markets, which may affect our suppliers, customers, and ourselves,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Success of integrating acquisitions,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to attract, retain, develop, and motivate key personnel,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest rate and financial market conditions,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Access to cash and cash equivalents held outside the U.S.,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of natural disasters, man-made disasters, public health issues (including pandemics), and cybersecurity incidents on our business, our customers or our contracted third parties,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of changes in foreign and domestic governmental policies, laws, or regulations,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The outcome of litigation in which the Company may be involved, particularly litigation or claims related to infringement of third-party intellectual property rights, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The outcome of any future tax matters or tax law changes.

We encourage readers of this report to review Part II, Item 1A, "Risk Factors" in this report for further discussion of issues that could affect the Company's future results. We undertake no obligation, other than as may be required by law, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances, or any other reason after the date of this report.

**New Accounting Pronouncements**

*Recently Issued Accounting Pronouncements Not Yet Adopted*

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires an annual tabular effective tax rate reconciliation disclosure including information for specified categories and jurisdiction levels, as well as, disclosure of income taxes paid, net of refunds received, disaggregated by federal, state/local, and significant foreign jurisdiction. This ASU will be effective for the Company's fiscal December 31, 2025 year-end. We are assessing the impact of this guidance on our disclosures; it will not have an impact on our results of operations, cash flows, or financial condition.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of certain categories of expenses that are included within expense captions presented on the Consolidated Statements of Operations on an annual and interim basis. This ASU will be effective for the Company's fiscal December 31, 2027 year-end and interim periods thereafter, with early adoption permitted. We are assessing the impact of this guidance on our disclosures; it will not have an impact on our results of operations, cash flows, or financial condition.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**Non-GAAP Measures**

The Company has provided reconciliations of the supplemental non-GAAP financial measures, as defined under the rules of the Securities and Exchange Commission, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP.

These supplemental non-GAAP financial measures – Consolidated Organic Net sales growth, AIT Organic Net sales growth, and EVM Organic Net sales growth – are presented because our management evaluates our financial results both including and excluding the effects of business acquisitions and foreign currency translation, as applicable. Management believes that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of our business from period to period and trends in our historical operating results. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for, or as an alternative to, and should be considered in conjunction with the GAAP financial measures presented.

---

| | |
|:---|:---|
| **Item 3.** | **Quantitative and Qualitative Disclosures About Market Risk** |

---

There were no material changes in the Company's market risk during the quarter ended June 28, 2025. For additional information on market risk, refer to Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" in the Annual Report on Form 10-K for the year ended December 31, 2024.

---

| | |
|:---|:---|
| **Item 4.** | **Controls and Procedures** |

---

**Management's Report on Disclosure Controls**

Our management is responsible for establishing and maintaining adequate disclosure controls as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to the Company's management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management assessed the effectiveness of our disclosure controls as of June 28, 2025. Based on this assessment and those criteria, our management believes that, as of June 28, 2025, our disclosure controls were effective.

**Changes in Internal Control over Financial Reporting** 

During the quarter ended June 28, 2025, there have been no changes in our internal controls that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Inherent Limitations on the Effectiveness of Controls** 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within Zebra have been prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**PART II - OTHER INFORMATION** 

---

| | |
|:---|:---|
| **Item 1.** | **Legal Proceedings** |

---

See Note 11, *Accrued Liabilities, Commitments and Contingencies* in the Notes to Consolidated Financial Statements included in this report.

---

| | |
|:---|:---|
| **Item 1A.** | **Risk Factors** |

---

In addition to the other information included in this report, you should carefully consider the factors discussed in Part I, Item 1A. "Risk Factors" in the Annual Report on Form 10-K for the year ended December 31, 2024, and the factors identified under "Safe Harbor" in Part I, Item 2 of this Quarterly Report on Form 10-Q, which could materially affect our business, financial condition, cash flows, or results of operations. The risks described in the Annual Report are not the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that the Company currently considers immaterial also may materially adversely affect its business, financial condition, and/or operating results. There have been no material changes to the risk factors included in our Annual Report for the year ended December 31, 2024.

---

| | |
|:---|:---|
| **Item 2.** | **Unregistered Sales of Equity Securities and Use of Proceeds** |

---

The following table sets forth information with respect to repurchases of the Company's common stock for the three months ended June 28, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares Purchased** | **Average Price Paid per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** <sup>(1)</sup> | **Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)** <sup>(1)</sup> |
| March 30, 2025 - April 26, 2025 | 303293 | $247.28 | 303293 | $646 |
| April 27, 2025 - May 24, 2025 | 83472 | 291.31 | 83472 | 622 |
| May 25, 2025 - June 28, 2025 | 87902 | 292.19 | 87902 | 596 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 474667 | $263.34 | 474667 | $596 |

---

(1)On May 17, 2022, the Company announced that its Board of Directors authorized a share repurchase program for up to $1 billion of its outstanding shares of common stock. Repurchases may be effected from time to time through open market purchases, including pursuant to a pre-set trading plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. As of June 28, 2025, the Company has cumulatively repurchased 1,388,599 shares of common stock for approximately $404 million, resulting in a remaining amount of share repurchases authorized under the May 2022 program of $596 million.

---

| | |
|:---|:---|
| **Item 5.** | **Other Information** |

---

The Company's Securities Transactions and Confidentiality Policy governs the purchase, sale, and/or other dispositions of the Company's securities by directors, officers and employees, and is designed to promote compliance with insider trading laws, rules and regulations, and any listing standards applicable to the Company. None of our directors or executive officers had in effect, adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended June 28, 2025.

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

---

| | |
|:---|:---|
| **Item 6.** | **Exhibits** |

---

---

| | |
|:---|:---|
| 31.1 | <u>[Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer](ex311q22025.htm)</u> |
| 31.2 | <u>[Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer](ex312q22025.htm)</u> |
| 32.1 | <u>[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex321q22025.htm)</u> |
| 32.2 | <u>[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex322q22025.htm)</u> |
| 101 | The following financial information from Zebra Technologies Corporation Quarterly Report on Form 10-Q, for the quarter ended June 28, 2025, formatted in Inline XBRL: (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive Income; (iv) the Consolidated Statements of Stockholders' Equity; (v) the Consolidated Statements of Cash Flows; and (vi) Notes to Consolidated Financial Statements. The instance document does not appear in the interactive data file because Inline XBRL tags are embedded in the iXBRL document. |
| 104 | The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 28, 2025 formatted in Inline XBRL (included in Exhibit 101). |

---

------

<u>[**Table of Contents**](#i0b3fb9ad24f84f9da8cf8d7f3f93d017_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **ZEBRA TECHNOLOGIES CORPORATION** | **ZEBRA TECHNOLOGIES CORPORATION** |
| Date: August 5, 2025 | By: | /s/ William J. Burns |
|  |  | William J. Burns |
|  |  | *Chief Executive Officer* |
| Date: August 5, 2025 | By: | /s/ Nathan Winters |
|  |  | Nathan Winters |
|  |  | *Chief Financial Officer* |

---

## Exhibit 31.1

**&nbsp;&nbsp;&nbsp;&nbsp;**

Exhibit 31.1

**CERTIFICATION**

I, William J. Burns, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this report on Form 10-Q of Zebra Technologies Corporation (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: &nbsp;&nbsp;&nbsp;&nbsp;August 5, 2025&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ William J. Burns&nbsp;&nbsp;&nbsp;&nbsp;</u> 

&nbsp;&nbsp;&nbsp;&nbsp;William J. Burns

&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer

## Exhibit 31.2

Exhibit 31.2

**CERTIFICATION**

I, Nathan Winters, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this report on Form 10-Q of Zebra Technologies Corporation (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: &nbsp;&nbsp;&nbsp;&nbsp;August 5, 2025&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Nathan Winters&nbsp;&nbsp;&nbsp;&nbsp;</u>

&nbsp;&nbsp;&nbsp;&nbsp;Nathan Winters

&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer

## Exhibit 32.1

Exhibit 32.1

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Zebra Technologies Corporation (the "Company") on Form 10-Q for the period that ended June 28, 2025, as filed with the Securities and Exchange Commission on the date hereof, I, William J. Burns, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:&nbsp;&nbsp;&nbsp;&nbsp;August 5, 2025&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ William J. Burns&nbsp;&nbsp;&nbsp;&nbsp;</u> 

&nbsp;&nbsp;&nbsp;&nbsp;William J. Burns

&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer

## Exhibit 32.2

Exhibit 32.2

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Zebra Technologies Corporation (the "Company") on Form 10-Q for the period that ended June 28, 2025, as filed with the Securities and Exchange Commission on the date hereof, I, Nathan Winters, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:&nbsp;&nbsp;&nbsp;&nbsp;August 5, 2025&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Nathan Winters&nbsp;&nbsp;&nbsp;&nbsp;</u>

&nbsp;&nbsp;&nbsp;&nbsp;Nathan Winters

&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer

<br>